[{"orgOrder":0,"company":"Glaceum","sponsor":"Catholic University of Korea | Kyunghee University Medical Center | Korea University Guro Hospital | Samsung Medical Center | Severance Hospital | Inje University | Hallym University Medical Center | The Catholic University of Korea Uijeongbu St.Marys Hos","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Vutiglabridin","moa":"Mitochondrial function","graph1":"Neurology","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Catholic University of Korea | Kyunghee University Medical Center | Korea University Guro Hospital | Samsung Medical Center | Severance Hospital | Inje University | Hallym University Medical Center | The Catholic University of Korea Uijeongbu St.Marys Hos","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Catholic University of Korea | Kyunghee University Medical Center | Korea University Guro Hospital | Samsung Medical Center | Severance Hospital | Inje University | Hallym University Medical Center | The Catholic University of Korea Uijeongbu St.Marys Hos"},{"orgOrder":0,"company":"Glaceum","sponsor":"Seoul National University Hospital | Seoul National University Bundang Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SOUTH KOREA","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"Vutiglabridin","moa":"Mitochondrial function","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Seoul National University Hospital | Seoul National University Bundang Hospital","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Seoul National University Hospital | Seoul National University Bundang Hospital"},{"orgOrder":0,"company":"Glaceum","sponsor":"Gangnam Severance Hospital | Seoul National University Bundang Hospital | Korea University Anam Hospital | Seoul National University Hospital | SMG-SNU Boramae Medical Center","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SOUTH KOREA","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"HSG4112","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Gangnam Severance Hospital | Seoul National University Bundang Hospital | Korea University Anam Hospital | Seoul National University Hospital | SMG-SNU Boramae Medical Center","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Gangnam Severance Hospital | Seoul National University Bundang Hospital | Korea University Anam Hospital | Seoul National University Hospital | SMG-SNU Boramae Medical Center"},{"orgOrder":0,"company":"Glaceum","sponsor":"Kyungpook National University Hospital | Seoul National University Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SOUTH KOREA","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"HSG4112","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Kyungpook National University Hospital | Seoul National University Hospital","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Kyungpook National University Hospital | Seoul National University Hospital"},{"orgOrder":0,"company":"Glaceum","sponsor":"Seoul National University Hospital | Kyungpook National University Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SOUTH KOREA","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"HSG4112","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Seoul National University Hospital | Kyungpook National University Hospital","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Seoul National University Hospital | Kyungpook National University Hospital"},{"orgOrder":0,"company":"Glaceum","sponsor":"Seoul National University Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SOUTH KOREA","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"HSG4112","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Seoul National University Hospital","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Seoul National University Hospital"},{"orgOrder":0,"company":"Glaceum","sponsor":"Seoul National University Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SOUTH KOREA","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"HSG4112","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Seoul National University Hospital","highestDevelopmentStatusID":"8","companyTruncated":"Glaceum \/ Seoul National University Hospital"},{"orgOrder":0,"company":"Glaceum","sponsor":"Seoul National University Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SOUTH KOREA","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"HGR4113","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase I","graph3":"Glaceum","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oral","sponsorNew":"Glaceum \/ Seoul National University Hospital","highestDevelopmentStatusID":"6","companyTruncated":"Glaceum \/ Seoul National University Hospital"}]

Find Clinical Drug Pipeline Developments & Deals by Glaceum

Glaceum
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check all FDF Dossiers for
this supplier

Contact Us
PharmaScopic.com

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Glaceum

South Korea

BIOHK2025

Not Confirmed

02

Glaceum

South Korea

BIOHK2025

Not Confirmed

03

Glaceum

South Korea

BIOHK2025

Not Confirmed

04

Glaceum

South Korea

BIOHK2025

Not Confirmed

05

Glaceum

South Korea

BIOHK2025

Not Confirmed

06

Glaceum

South Korea

BIOHK2025

Not Confirmed

07

Glaceum

South Korea

BIOHK2025

Not Confirmed

08

Glaceum

South Korea

BIOHK2025

Not Confirmed